2 Biotech Stocks Showing Serious Relative Strength

Published by
ValueWalk

These Biotech Stocks Have Been Brilliant in 2022 Thus FarBiotechnology is known to be one of the most volatile sectors in the market, which is why it’s been so interesting to see certain stocks in that area showing lots of relative strength during a volatile first few months of the year. Investors should note that it is especially important to choose carefully when adding exposure in this area of the market, as many of these companies are one FDA approval away from success and failure. A great way to potentially take advantage of the upside that biotech stocks have to offer is by narrowing you…

Read More

See also  Sondland: Yes, there was a quid pro quo

Leave a Reply